Related Experiment Videos

Insulin edema in diabetes mellitus associated with the 3243 mitochondrial tRNA(Leu(UUR)) mutation; case reports

Y Suzuki1, H Kadowaki, M Taniyama

  • 1Saiseikai Central Hospital, Tokyo, Japan.

Insights

Mitochondrial dysfunction may cause insulin edema in patients with diabetes mellitus due to the 3243 mitochondrial tRNA mutation (DM-Mt3243). This rare complication, linked to mitochondrial diabetes, warrants further investigation into its underlying mechanisms.

Area of Science:

  • Endocrinology
  • Genetics
  • Metabolic Diseases

Background:

  • Diabetes mellitus due to the 3243 mitochondrial tRNA mutation (DM-Mt3243) is a specific subtype of diabetes.
  • Insulin therapy is a cornerstone in managing diabetes, but can have side effects.

Observation:

  • A patient with DM-Mt3243 developed insulin edema and hepatic dysfunction after initiating insulin therapy.
  • This adverse event was not observed in 197 non-mutant non-insulin-dependent diabetes mellitus patients.
  • Similar leg edema was noted in another DM-Mt3243 patient and responded to coenzyme Q10 in two others.

Findings:

  • The study suggests a potential role for mitochondrial dysfunction in the etiology of insulin edema.
  • Possible mechanisms include vasomotor changes from rapid glycemic control, myocardial dysfunction, or hepatic reoxygenation injury.
  • Increased succinate dehydrogenase reactivity in vessels was observed in the patient with insulin edema.

Implications:

  • Mitochondrial dysfunction may be a significant factor in the development of insulin edema in specific diabetes populations.
  • Further research is needed to elucidate the precise mechanisms linking mitochondrial health to insulin-induced complications.
  • Coenzyme Q10 may be a potential therapeutic agent for managing leg edema in DM-Mt3243 patients.

Related Concept Videos